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Impact of clinical pharmacist medication review upon enrollment in a
Program for All-inclusive Care of the Elderly (PACE)

Health & Services

Adam Olesen, PharmD; Kristen Wendell, PharmD, BCGP

Results

Background
• The Program of All-Inclusive Care of the Elderly
(PACE) is a nation-wide medical care model that
offers comprehensive community-based care for
medically frail participants eligible for nursing home
level of care. On national average, a PACE participant
has six chronic conditions and is taking nine
maintenance medications.1
• A minority of PACE programs (approximately five of
126 programs nationwide) embed geriatric clinical
specialist pharmacists within the PACE care team.
• This study was performed within a PACE network
associated with a tertiary care center that assigns
geriatric clinical pharmacists to patient care teams
with a participant ratio of approximately 300 for each
pharmacist FTE.
• Pharmacist duties include patient assessments,
disease state management, and medication review at
enrollment and at subsequent transitions of care.
• Upon enrollment with the PACE facility, every
participant’s medication profile is reviewed by a
clinical pharmacist, who then works with both the
participant and PCP to address drug-related issues.
• Pharmacist-led interventions are presumed to improve
patient care and reduce cost. However, there is not
currently a process in place to objectively capture and
evaluate pharmacist work.
• Previous studies have demonstrated clinical and cost
saving benefits of pharmacist involvement in
transitions of care of medically complex patients.2

Purpose
To quantify and characterize the number and type of
interventions and recommendations made by
pharmacists at PACE program enrollment

Methodology

Study Design
Retrospective analysis of pharmacist interventions and
recommendations completed at time of enrollment for all
new participants with enrollment dates from November
1, 2019 to January 31, 2020
Primary Endpoint
Composite analysis of:
• Number of interventions completed upon enrollment
• Types of interventions
Secondary Endpoints
• Percentage of recommendations presented by
pharmacists that are implemented at enrollment and
within two months following enrollment. Progression
towards a recommendation was counted as accepted
• Whether the intervention pertains to a medication on
the 2019 Beers List
• Number of recommendations of which the primary
goal was to reduce polypharmacy(defined as unused
medications on an enrollee's medication profile)
Inclusion Criteria
All new PACE enrollees within the study period
Exclusion Criteria
Disenrolled from PACE program during the study period
Data Collection
Prior to initiation of study, pharmacists were trained on
intervention documentation system within electronic
health record (EPIC i-Vents)

Discussion

Interventions documented for 108 enrollees
across 3 months
n=524

Implemented at
enrollment

Implemented within
two months

Awaiting Provider
Approval

n=356 (68%)

n=79 (15%)

n=89 (17%)

Breakdown of Interventions (n=524)
Intervention

Number of
interventions
made

Interventions
accepted at
enrollment, n
(%)

Therapy Optimization
Drug Change
Drug Discontinuation
Drug Addition
Renal Dose Adjust
Formulary Interchange

238
88
86
61
3
71

145
48 (55)
62 (72)
33 (54)
2 (67)
62 (87)

Interventions
accepted between
enrollment date
and two months, n
(% of remaining)
37
16 (40)
12 (50)
8 (29)
0 (0)
9 (13)

Polypharmacy Reduction

52

51 (98)

1 (2)

52 (100)

Lab Recommendations
Beers List Medication

47
41

34 (72)
29 (71)

10 (21)
2 (5)

44 (94)
31 (76)

Total interventions
implemented at 2
months, n (%)
181 (76)
64 (73)
74 (86)
41 (67)
2 (67)
71 (100)

Screening
33
Recommendations
Related to anticoagulation 13

5 (15)

14 (42)

19 (58)

9 (69)

4 (31)

13 (100)

Patient's Own Medication
Minor ADR addressed
Specialist Referral
Prior Authorization
Fall Prevention

11 (92)
6 (75)
0 (0)
3 (100)
1 (50)

0 (0)
1 (13)
2 (50)
-0

11 (92)
7 (88)
2 (50)
3 (100)
1 (50)

12
8
4
3
2

Accepted at enrollment
100
90
80
70
60
50
40

Accepted within 2 months

Awaiting

• Pharmacists were able to implement 68% of their
interventions on date of enrollment. Interventions most
commonly made prior to establishing a patient-provider
relationship include discontinuing medications without
indication, formulary interchanges, and addressing
polypharmacy.
• Of the 168 interventions not accepted at enrollment, 47%
were implemented within two months. This resulted in a
cumulative total of 83% of pharmacist recommendations
being implemented within two months of enrollment. The
most common of these were therapeutic optimization,
recommended screenings, recommended drug
discontinuations, and recommended labs to obtain.
• There were 192 drugs for 52 patients were discontinued due
to polypharmacy. These were defined as unused drugs that
were possessed by the patient or on their prescription list.
This indicates that many geriatric patients have many unused
or unnecessary drugs on their medication profile that can lead
to complications in their care.
• Pharmacists recommended the discontinuation of 74 drugs
due to lack of indication. These are medications the patients
were still taking. Discontinuing these medications is an
effective way to reduce pill burden and ADRs in geriatric
patients.
• Therapy optimization (drug change, addition, discontinuation,
or dose adjustment) comprised 45% of pharmacist
interventions. This demonstrates that a large amount of the
interventions performed by pharmacists includes clinical
decision making that may best benefit the patient. A total of
76% of these recommendations were accepted across the
study period, indicating that provider’s clinical thought
processes may be in agreement with that of the pharmacists.
• Investigators found minimal need to adjust i-Vent coding or to
retrain pharmacists on appropriate use. This suggests that
pharmacist training on use of the system has been adequate.
Limitations
• While coding required minimal adjustments, it is still possible
that a pharmacist coded an intervention as one type i-Vent
while it was more applicable as another.
• If an intervention may have applied to multiple i-Vents,
pharmacists were required to identify a primary reason for
their recommendation. This subjective decision-making was
pharmacist-specific and does risk coding bias.
Conclusions
• Patients enrolling in PACE programs are often medically
complex and stand to benefit from medication review by a
pharmacist.
• Pharmacists make quantifiable interventions that contribute to
transition into a Program of All-include Care for the Elderly.
• The most common interventions completed at enrollment
were therapy optimization, drug discontinuation, and
formulary interchanges.
• The recommendations most accepted at two-month follow-up
were related to therapy optimization.

Next Steps
• An evaluation of the financial impact these interventions
have on the PACE program.
• Analysis of the interventions and recommendations a
pharmacist makes every month on participants that are
already enrolled with the PACE program.
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